This past summer Professor Kathryn Uhrich, an Associate Professor in Chemistry, and Associate Faculty Member in Biomedical Engineering spun off a company, Polymerix Corp. to develop new polymeric drugs with unique properties. The first example, polyaspirin, is salicylic acid formulated as a polymer.